CurAegis Technologies, Inc. (CRGS)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
CurAegis Technologies, Inc. (CRGS) trades at $0.00. CurAegis Technologies, Inc. is a technology company formerly focused on wellness, safety, and power technologies. The company is currently undergoing Chapter 7 liquidation after an involuntary petition was approved in 2021. Sector: Technology.
Last analyzed: Mar 18, 2026Analyst Coverage for CRGS: CRGS does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CRGS against Technology peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
CRGS: 1/1 perspectives are bearish.
CurAegis Technologies, Inc. (CRGS) Technology Profile & Competitive Position
CurAegis Technologies, Inc., previously involved in developing wellness, safety, and power technologies, is currently undergoing Chapter 7 liquidation. With minimal current operations and a history dating back to 1996, the company's future is uncertain amidst a competitive technology landscape. The company trades on the OTC market.
What Is the Investment Thesis for CRGS?
CurAegis Technologies, Inc. faces substantial challenges given its current Chapter 7 liquidation status approved in August 2021. The company's negative profit margin of -28506.7% and high beta of -83.77 reflect its distressed financial condition. The absence of significant operations and reliance on past technology development efforts in wellness, safety, and power sectors further complicate any potential turnaround. Investors should carefully consider the implications of the bankruptcy proceedings and the absence of current revenue streams when evaluating CRGS.
Based on FMP financials and quantitative analysis
CRGS Key Highlights
- Profit Margin: -28506.7%, indicating significant losses and financial distress.
- Gross Margin: 13.3%, reflecting limited profitability on past sales.
- Beta: -83.77, suggesting an inverse correlation with market movements, though potentially unreliable given the company's current state.
- Dividend Yield: None, as the company does not currently offer dividends.
- Chapter 7 Liquidation: Approved by the U.S. Bankruptcy Court, signaling a wind-down of operations.
Who Are CRGS's Competitors?
CRGS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| WATT Energous Corporation | $24.69 | +2.16% | $36.67M | 65 |
| SELX Selecta Biosciences, Inc. | $0.15 | -3.73% | $5.83M | 64 |
| APH Amphenol Corporation | $154.75 | +1.51% | 191B | 63 |
| SATL Satellogic Inc. | $6.90 | -8.25% | $829.08M | 62 |
| HXGBY Hexagon AB (publ) | $10.02 | -0.05% | $26.88B | 52 |
| MPTI M-tron Industries, Inc. | $99.64 | +3.41% | $302.60M | 52 |
| SMOPF Smartoptics Group AS | $5.32 | -3.27% | $521.60M | 52 |
| NEON Neonode Inc. | $1.20 | +0.42% | $20.14M | 52 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CRGS's Key Strengths?
- Historical focus on technology development.
- Prior experience in wellness, safety, and power sectors.
- Existing intellectual property (potentially).
What Are CRGS's Weaknesses?
- Chapter 7 liquidation status.
- Lack of significant current operations.
- Negative profit margin.
- Limited financial resources.
What Could Drive CRGS Stock Higher?
- Potential sale of remaining assets during liquidation.
- Resolution of bankruptcy proceedings.
- Any potential licensing agreements for existing technology.
What Are the Key Risks for CRGS?
- Chapter 7 liquidation resulting in complete loss of investment.
- Lack of interest in acquiring the company's assets.
- Legal challenges or complications during bankruptcy proceedings.
- Limited liquidity and high volatility in the OTC market.
- Delisting from the OTC market.
What Are the Growth Opportunities for CRGS?
- Restructuring and Asset Sale: If CurAegis possesses valuable intellectual property or assets, a potential growth opportunity lies in restructuring or selling these assets to other companies in the technology sector. The market for technology assets is substantial, with companies regularly acquiring patents and technologies to enhance their product offerings. Timeline: Within the next 1-2 years, depending on the bankruptcy proceedings.
- Emergence from Bankruptcy: Although unlikely, if CurAegis can successfully navigate its Chapter 7 liquidation and emerge with a viable business plan, it could potentially re-enter the market. This would require significant restructuring and securing new funding. The technology sector is receptive to innovative ideas, but the company would need a strong value proposition. Timeline: 3-5 years, contingent on bankruptcy outcomes.
- Licensing of Intellectual Property: CurAegis could explore licensing its existing intellectual property to other companies in the wellness, safety, or power technology sectors. Licensing agreements can provide a revenue stream without requiring significant operational involvement. The market for technology licensing is robust, with numerous companies seeking to enhance their product portfolios. Timeline: Ongoing, dependent on identifying suitable licensees.
- Acquisition by Another Company: CurAegis could be acquired by another company seeking to acquire its technology or assets. An acquisition could provide an exit strategy for stakeholders and potentially revive some of the company's past innovations. The market for mergers and acquisitions in the technology sector is active, with companies constantly seeking strategic acquisitions. Timeline: Within the next 1-3 years, depending on market conditions.
- New Technology Development: While highly speculative given the current circumstances, CurAegis could potentially pivot to developing new technologies in emerging areas such as renewable energy or IoT devices. This would require a significant infusion of capital and a complete overhaul of the company's business model. The market for emerging technologies is rapidly growing, but competition is fierce. Timeline: 5+ years, contingent on securing funding and developing a viable product.
What Opportunities Does CRGS Have?
- Potential sale of assets or intellectual property.
- Restructuring and emergence from bankruptcy (unlikely).
- Licensing agreements for existing technology.
What Threats Does CRGS Face?
- Continued liquidation proceedings.
- Lack of investor confidence.
- Inability to secure new funding.
- Competition from established technology companies.
What Are CRGS's Competitive Advantages?
- Historically, the company's moat was based on proprietary technology.
- Brand recognition (limited).
- Intellectual property (potentially still valuable, but untested).
What Does CRGS Do?
CurAegis Technologies, Inc., originally founded in 1996 as Torvec, Inc., underwent a name change in June 2016. Based in Rochester, New York, the company was once engaged in the development and marketing of technologies aimed at the wellness, safety, and power sectors. However, CurAegis Technologies, Inc. does not currently have significant operations. The company's history took a turn on August 4, 2021, when an involuntary petition for liquidation under Chapter 7 was filed against it in the U.S. Bankruptcy Court for the Western District of New York. This petition was subsequently approved by the Court on August 31, 2021. The company's past involvement in technology development contrasts sharply with its current state of liquidation, marking a significant shift in its trajectory. With a small team of 7 employees, the company's activities are currently limited to the bankruptcy proceedings.
What Products and Services Does CRGS Offer?
- Formerly developed technologies in the wellness sector.
- Previously marketed safety-related technology products.
- Engaged in the development of power-related technologies.
- Undergoing Chapter 7 liquidation proceedings.
- Based in Rochester, New York.
- Currently has minimal operational activities.
How Does CRGS Make Money?
- Historically generated revenue through the sale of technology products.
- Focused on developing and marketing innovations in wellness, safety, and power.
- Currently, the business model is centered around managing the liquidation process.
What Industry Does CRGS Operate In?
CurAegis Technologies, Inc. previously operated within the technology sector, specifically focusing on hardware, equipment, and parts related to wellness, safety, and power technologies. The industry is characterized by rapid innovation and intense competition. However, given CurAegis's current liquidation status, it is no longer an active participant in this landscape. Competitors like CCTR, EBIXQ, ENDRF, GSIL, and IINX operate in various segments of the technology sector, but CurAegis's financial distress sets it apart.
Who Are CRGS's Key Customers?
- Historically targeted customers interested in wellness products.
- Focused on customers seeking safety-related technology solutions.
- Previously served customers in the power technology sector.
CRGS Financials
CRGS Latest News
No recent news available for CRGS.
CRGS Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CRGS.
Price Targets
Wall Street price target analysis for CRGS.
CRGS MoonshotScore
What does this score mean?
The MoonshotScore rates CRGS's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Hardware, Equipment & PartsLeadership: James R. Donnelly
CEO
James R. Donnelly serves as the CEO of CurAegis Technologies, Inc. He is responsible for managing the company's operations, which currently involve overseeing the Chapter 7 liquidation process. His background includes experience in technology management and strategic planning. He leads a small team of 7 employees during this challenging period. Additional details regarding his previous roles and educational background are not available.
Track Record: Given the company's current state of liquidation, it is difficult to assess James R. Donnelly's track record in terms of positive achievements or strategic successes. His primary focus is now on managing the company's assets and liabilities during the bankruptcy proceedings. There is no available information regarding key achievements or milestones under his leadership.
CRGS OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that CurAegis Technologies, Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited information available to investors and may be subject to greater risks due to less stringent regulatory oversight compared to companies listed on major exchanges like the NYSE or NASDAQ. Trading on the OTC Other tier typically involves higher volatility and lower liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited or no financial disclosure.
- High potential for fraud or manipulation.
- Extreme price volatility.
- Illiquidity and difficulty in trading shares.
- Risk of complete loss of investment.
- Verify the company's legal status and registration.
- Attempt to obtain any available financial information.
- Assess the company's assets and liabilities.
- Understand the details of the Chapter 7 liquidation process.
- Evaluate the potential for any recovery of investment.
- Consult with a financial advisor before investing.
- Be aware of the risks associated with OTC trading.
- Historical operating history in the technology sector.
- Prior involvement in technology development.
- Existing intellectual property (potentially).
- Publicly traded status (albeit on the OTC market).
- CEO in place.
What Investors Ask About CurAegis Technologies, Inc. (CRGS) — Technology
What does CurAegis Technologies, Inc. do?
CurAegis Technologies, Inc. previously focused on developing and marketing technologies in the wellness, safety, and power sectors. However, the company is currently undergoing Chapter 7 liquidation, meaning it does not have significant ongoing operations. The company's activities are now primarily centered around managing the liquidation process and potentially selling off its remaining assets. Investors should be aware that the company's historical business model is no longer relevant given its current financial situation.
What do analysts say about CRGS stock?
Given CurAegis Technologies, Inc.'s current Chapter 7 liquidation status, there is limited to no analyst coverage available. The company's financial distress and lack of significant operations make it a high-risk investment. Key valuation metrics such as price-to-earnings ratio are not meaningful in this context. Investors should conduct their own thorough due diligence and consider the risks associated with investing in a company undergoing liquidation. There is no analyst consensus available.
What are the main risks for CRGS?
The primary risk for CurAegis Technologies, Inc. is the ongoing Chapter 7 liquidation, which could result in a complete loss of investment for shareholders. Additional risks include limited liquidity in the OTC market, potential legal challenges during the bankruptcy proceedings, and the possibility of the company being delisted from the OTC market. Investors should carefully consider these risks before investing in CRGS, as the company's financial condition is highly precarious.
What are the key factors to evaluate for CRGS?
Evaluate CRGS on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does CRGS data refresh on this page?
CRGS prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven CRGS's recent stock price performance?
CurAegis Technologies, Inc. (CRGS) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Historical focus on technology development. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CRGS overvalued or undervalued right now?
Valuing CurAegis Technologies, Inc. (CRGS) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying CRGS?
Before investing in CurAegis Technologies, Inc. (CRGS), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available sources and may be incomplete due to the company's liquidation status.
- Financial data may not be current or reliable.